Official title and information are available only for Plus and Premium subscribers.
Technology The subject of this licensing opportunity is the use of modified natural polysaccharides for the treatment and prevention of viral infections caused by the coronaviruses. The invention may be particularly useful for controlling potentially deadly SARS infections.
To see the additional information details please login and subscribe to a Plus or Premium account.
